USD 2.94
(1.03%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -669.32 Million CNY | 31.73% |
2022 | -980.4 Million CNY | -23.0% |
2021 | -797.06 Million CNY | -93.27% |
2020 | -412.4 Million CNY | -143.89% |
2019 | -169.09 Million CNY | -4.77% |
2018 | -161.39 Million CNY | -33.53% |
2017 | -120.86 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -125.82 Million CNY | 24.35% |
2024 Q2 | -111.21 Million CNY | 11.61% |
2023 Q3 | -178.81 Million CNY | -31.75% |
2023 Q1 | -188.45 Million CNY | 13.33% |
2023 Q2 | -135.72 Million CNY | 27.98% |
2023 FY | -669.32 Million CNY | 31.73% |
2023 Q4 | -166.32 Million CNY | 6.99% |
2022 Q4 | -217.44 Million CNY | 7.33% |
2022 Q3 | -234.64 Million CNY | 11.61% |
2022 Q2 | -265.46 Million CNY | -0.99% |
2022 FY | -980.4 Million CNY | -23.0% |
2022 Q1 | -262.86 Million CNY | -4.26% |
2021 FY | -797.06 Million CNY | -93.27% |
2021 Q4 | -252.12 Million CNY | -47.41% |
2021 Q3 | -171.04 Million CNY | 15.34% |
2021 Q2 | -202.02 Million CNY | -17.55% |
2021 Q1 | -171.86 Million CNY | -10.61% |
2020 Q2 | -73.04 Million CNY | -23.09% |
2020 FY | -412.4 Million CNY | -143.89% |
2020 Q1 | -59.34 Million CNY | 37.85% |
2020 Q4 | -155.37 Million CNY | -24.65% |
2020 Q3 | -124.64 Million CNY | -70.65% |
2019 Q2 | -28.47 Million CNY | -146.12% |
2019 Q4 | -95.48 Million CNY | -184.49% |
2019 Q3 | -33.56 Million CNY | -17.86% |
2019 Q1 | -11.57 Million CNY | 76.02% |
2019 FY | -169.09 Million CNY | -4.77% |
2018 FY | -161.39 Million CNY | -33.53% |
2018 Q4 | -48.24 Million CNY | 0.0% |
2017 FY | -120.86 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aspira Women's Health Inc. | -18.85 Million USD | -3450.398% |
bioAffinity Technologies, Inc. | -7.97 Million USD | -8294.605% |
Biodesix, Inc. | -41.34 Million USD | -1518.986% |
IDEXX Laboratories, Inc. | 1.09 Billion USD | 161.007% |
Illumina, Inc. | -1.06 Billion USD | 37.388% |
Standard BioTools Inc. | -76.6 Million USD | -773.787% |
23andMe Holding Co. | -321.35 Million USD | -108.28% |
NeoGenomics, Inc. | -107.73 Million USD | -521.26% |
Neogen Corporation | 58.66 Million USD | 1240.959% |
Inotiv, Inc. | -81.46 Million USD | -721.656% |
Psychemedics Corporation | -2.92 Million USD | -22814.105% |
RadNet, Inc. | 98.69 Million USD | 778.157% |
Star Equity Holdings, Inc. | -4.34 Million USD | -15300.851% |
T2 Biosystems, Inc. | -49.66 Million USD | -1247.699% |
Castle Biosciences, Inc. | -67.97 Million USD | -884.629% |
Exact Sciences Corporation | -215.01 Million USD | -211.295% |
Prenetics Global Limited | -52.51 Million USD | -1174.568% |
iSpecimen Inc. | -11.16 Million USD | -5892.48% |
OpGen, Inc. | -15.68 Million USD | -4166.322% |
Neuronetics, Inc. | -30.55 Million USD | -2090.617% |
Precipio, Inc. | -7.62 Million USD | -8683.74% |
Intelligent Bio Solutions Inc. | -10.28 Million USD | -6408.895% |
Exagen Inc. | -22.83 Million USD | -2830.862% |
Bionano Genomics, Inc. | -215.24 Million USD | -210.958% |
CareDx, Inc | -101.9 Million USD | -556.841% |
Check-Cap Ltd. | -19.28 Million USD | -3370.322% |
Twist Bioscience Corporation | -220.83 Million USD | -203.092% |
Guardant Health, Inc. | -564.72 Million USD | -18.522% |
BioNexus Gene Lab Corp. | -2.59 Million USD | -25706.759% |
Natera, Inc. | -446.24 Million USD | -49.99% |
Fulgent Genetics, Inc. | -72.69 Million USD | -820.725% |
Sera Prognostics, Inc. | -39.82 Million USD | -1580.824% |
OPKO Health, Inc. | -157.02 Million USD | -326.262% |
Personalis, Inc. | -109.93 Million USD | -508.828% |
Aclaris Therapeutics, Inc. | -97.35 Million USD | -587.491% |
Applied DNA Sciences, Inc. | -10.95 Million USD | -6010.685% |
Myriad Genetics, Inc. | -123.7 Million USD | -441.084% |
ICON Public Limited Company | 956.15 Million USD | 170.002% |
Star Equity Holdings, Inc. | -4.34 Million USD | -15300.851% |
MDxHealth SA | -27.32 Million USD | -2349.303% |
Prenetics Global Limited | -52.51 Million USD | -1174.568% |
DarioHealth Corp. | -56.18 Million USD | -1091.196% |
ENDRA Life Sciences Inc. | -10.52 Million USD | -6261.922% |
Medpace Holdings, Inc. | 336.82 Million USD | 298.715% |
Mainz Biomed B.V. | -26.64 Million USD | -2412.025% |
Trinity Biotech plc | -27.04 Million USD | -2374.842% |
Sotera Health Company | 276.69 Million USD | 341.901% |
bioAffinity Technologies, Inc. | -7.97 Million USD | -8294.605% |